Zobrazeno 1 - 10
of 126
pro vyhledávání: '"Emilie Jouanjus"'
Autor:
Marine Tambon, Camille Ponté, Emilie Jouanjus, Nathalie Fouilhé, Joelle Micallef, Maryse Lapeyre-Mestre, the French Addictovigilance Network (FAN)
Publikováno v:
Frontiers in Psychiatry, Vol 12 (2021)
Introduction: Gabapentinoid drugs (gabapentin and pregabalin) are widely used worldwide for epileptic and pain disorders. First signals of gabapentinoid abuse occurred in the last decade. This study aims to describe clinical characteristics of gabape
Externí odkaz:
https://doaj.org/article/16497cd9de54454ea330638fbc4a53c4
Publikováno v:
Addiction. 118:771-775
The current opioid epidemic in the United States began 20 years ago and has become the leading cause of accidental deaths in the country. This crisis prompted us to explore trends in opioid abuse and dependence worldwide. We sought to identify other
Autor:
Laurine Diaz, Céline Eiden, Emilie Jouanjus, Elisabeth Frauger, Nathalie Fouilhé, Samira Djezzar, Valérie Gibaja, Alexandra Boucher, Reynald Le Boisselier, Frédéric Libert, Anne-Sylvie Caous, Emilie Monzon, Marylène Guerlais, Amélie Daveluy, Bernard Fauconneau, Hélène Peyrière
Publikováno v:
Therapies.
Autor:
Emilie, Jouanjus, Valérie, Gibaja, Florence, Fabre, Maryse, Lapeyre-Mestre, Karima, Hider-Mlynarz
Publikováno v:
British Journal of Clinical Pharmacology. 88:1713-1721
BACKGROUND The French Ministry of Health scheduled opioid cough suppressants as prescription-only drugs on July 12th , 2017. The present study assessed the impact of this regulation on the diversion modalities of the concerned drugs and the related d
Publikováno v:
Clinical Drug Investigation. 41:701-710
The present survey was a preliminary to a European research project on the attitude and knowledge of healthcare professionals towards the use of medical cannabis. The objective was to evaluate the readability, understandability, and relevance of a fi
Autor:
Emilie, Bouquet, Stéphanie, Pain, Céline, Eiden, Emilie, Jouanjus, Nathalie, Richard, Bernard, Fauconneau, Marie-Christine, Pérault-Pochat, Juliana, Tournebize
Publikováno v:
British Journal of Clinical Pharmacology. 87:3925-3937
Aims To describe the adverse events (AEs) of recreational cannabis use in France between 2012 and 2017. Methods AEs related to recreational cannabis use, alone or in combination with alcohol and/or tobacco reported to the French Addictovigilance Netw
Publikováno v:
British journal of clinical pharmacology. 88(11)
Ketamine and dextromethorphan are widely abused psychoactive substances. Inhibition of N-methyl-d-aspartate receptors (NMDARs) results in neurobehavioural effects including hallucinations, "out of body" sensations and dissociative effects. However, l
Autor:
Maryse Lapeyre-Mestre, Emilie Jouanjus
Publikováno v:
La Presse Médicale Formation. 1:355-363
Points essentiels La forte prevalence d’utilisation du cannabis en France, en particulier chez les adolescents et jeunes adultes, ainsi que des presentations cliniques atypiques au sein de cette population font craindre la survenue d’effets indes
Autor:
Emilie Jouanjus, Valérie Wolff
Publikováno v:
La Presse Médicale Formation. 1:364-372
Points essentiels L’evolution du statut legal du cannabis est un element contributif a l’elargissement de la consommation de ce produit, dont la prevalence a augmente de 19 % au cours de la decennie 2010-2020. Par ailleurs, la legalisation de l
Autor:
Hélène Peyrière, Alexandra Boucher, Juliana Tournebize, Amélie Daveluy, Ghada Miremont, Sylvie Deheul, Nathalie Fouilhé, Maryse Lapeyre-Mestre, Emilie Jouanjus, Joëlle Micallef, Céline Eiden, Anne Roussin, Michel Mallaret, Reynald Le Boisselier, Émilie Bouquet, Leila Chaouachi, Chistine Fournier-Choma, Cécile Chevallier, Valérie Gibaja, Elisabeth Frauger, Marylène Guerlais
Publikováno v:
Thérapie
Thérapie, 2020, 75 (4), pp.343-354. ⟨10.1016/j.therap.2020.06.006⟩
Therapies
Therapie
Thérapie, 2020, 75 (4), pp.343-354. ⟨10.1016/j.therap.2020.06.006⟩
Therapies
Therapie
Addictovigilance is a safety monitoring targeted at substances with potential for abuse and dependence. This vigilance was involved during the period of COVID-19 epidemic due to the significant changes in access to drugs and psychological disruption